Biden Administration Expands CCBHC Medicaid Program to 10 New States: A Game-Changer for Behavioral Health Care Access
The Biden administration has taken a significant step forward in addressing the mental health and substance use crisis in the United States. In an...
Addressing the Fentanyl Crisis: A Senate Hearing on Improving Access to Fentanyl Treatment Options
The fentanyl epidemic in the United States continues to devastate communities, with overdose deaths reaching catastrophic levels. As lawmakers grapple with the best course...
Navigating the New Era of Behavioral Health M&A Trends: The Rise of Seller Notes and Earnouts
The behavioral health sector experienced a major wave of M&A activity during and shortly after the COVID-19 pandemic. However, since 2022, the landscape has...
The MAMA Act: Tackling the Crisis in Maternal Mental Health Care Access
Behavioral health-related issues—especially suicide and drug overdoses—have tragically become the leading cause of pregnancy-related deaths in the United States, now accounting for over 22%...
Behavioral Health M&A Holds Steady in 2024: Private Equity Leads While Venture Capital Swings Big
In a year when the health care landscape faces a host of challenges, including high interest rates, increased regulatory scrutiny, and general economic pressures,...
Navigating the Changing Landscape of Healthcare Dealmaking: How State Healthcare Laws Are Impacting Behavioral Health Transactions
State governments are becoming increasingly critical of health care dealmaking, and this trend is poised to have a significant impact on the behavioral health...
